Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.463 SEK | -1.49% | -7.40% | -11.47% |
Apr. 16 | Mendus AB Announces Board Changes | CI |
Mar. 27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
- Stock Market
- Equities
- IMMU Stock
- News Mendus AB